RESP — Respiratorius AB (publ) Share News
0.000.00%
- SEK19.44m
- SEK19.44m
- SEK0.03m
Brief: Respiratorius AB - Q4 Pretax Loss SEK 1.9 Million
Brief: Respiratorius Q3 Pretax Loss Widens To Sek 1.6 Million
Brief: Respiratorius Q2 Pre-Tax Loss Widens To 2.1 Mln
Brief: Respiratorius Rights Issue Subscribed To 213.8%
Brief: Respiratorius Q1 Pre-Tax Loss Widens To SEK 1.9 Million
Brief: Respiratorius Intends To Issue Units Of About SEK 25.1 Mln In Rights Offering
Brief: Respiratorius Proposes Rights Issue Of Units
Brief: Respiratorius Takes Loan Of SEK 5 Million
Brief: Respiratorius Q4 Pre-Tax Loss Narrows To SEK 0.9 Mln
Brief: Respiratorius Q3 Pre-Tax Loss Sek 1.3 Million
Brief: Respiratorius: CIPO Announces Intent To Grant Patent For VAL001
Brief: Respiratorius Announces Positive Results For RES030-085
Brief: Respiratorius: Agreement With Partner International For Negotiation And Sale For Val001
Brief: Respiratorius Q3 Pre-Tax Loss At SEK 1.2 Million
Brief: Respiratorius Says US And Korea Grant Patents For VAL001
Brief: Respiratorius: Patent Application Submitted For New Substance In KOL And Severe Asthma
Brief: Respiratorius: Mexican Patent Office Allows Patent For RESP3000
Brief: Respiratorius Presents Positive Results From Clinical Studies Of VAL001
Brief: Respiratorius: EPO Allows Patent For RESP3000